- Research Article
- 10.1016/j.jval.2024.10.378
EE94 Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for the Treatment of Moderate-to-Severe Active Crohn's Disease in Greece
- Dec 01, 2024
- Value in Health
- K Vellopoulou + 3 more +3
Publications from 2021 to 2026
Showing 2 of 2 papers
EE94 Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for the Treatment of Moderate-to-Severe Active Crohn's Disease in Greece
The optimal use of renewable energy sources—The case of the new international “Makedonia” airport of Thessaloniki, Greece